Factors predisposing to thrombosis after major joint arthroplasty

Figure 1 Comparison of platelet counts fluctuation between low-molecular-weight heparin and fondaparinux. LMWH: Low-molecular-weight heparin; PLT: Platelet.

Figure 2 Percentage of patients with anti-platelet factor 4/heparin antibodies according to pharmacologic agent (P < 0. 05). LMWH: Low-molecular-weight heparin.

Figure 3 Correlation of thrombocytopenia, anti-platelet factor 4/heparin antibodies formation, heparin-induced thrombocytopenia, mutation of coagulation factors, and development of thrombosis. HIT: Heparin-induced thrombocytopenia.